SCHEMBL4733603

SCHEMBL4733603

CC(C)N(C(=O)c1ccc(Cl)cc1Cl)c1cc(-c2ccc(-c3cn4ccccc4n3)cc2)sc1C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 1/20 0.44
▸ PTGS2 P35354 1/20 0.44
▸ NPC1 O15118 5/20 0.44
▸ RAB9A P51151 5/20 0.44
▸ KDM4E B2RXH2 9/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ HPGD P15428 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ LMNA P02545 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ GFER P55789 3/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ CLK1 P49759 1/20 0.38
▸ DYRK1A Q13627 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4730549 0.92 PTGS1 (0.43) PTGS1PTGS2NPC1RAB9AKDM4E
SCHEMBL4733487 0.92 RAB9A (0.42) PTGS1PTGS2NPC1RAB9AKDM4E
SCHEMBL14223410 0.86 TP53 (0.40) NPC1RAB9AALDH1A1SMN1; SMN2HPGD
SCHEMBL4732231 0.85 PTGS1 (0.44) PTGS1PTGS2NPC1RAB9AKDM4E
SCHEMBL4731381 0.84 RAB9A (0.41) PTGS1PTGS2NPC1RAB9AKDM4E
SCHEMBL2158689 0.84 CYP1A2 (0.40) SMN1; SMN2CYP2C19MAPT
SCHEMBL4732771 0.82 APOBEC3A (0.34) NPC1RAB9AKDM4ESMN1; SMN2HPGD
SCHEMBL2157940 0.80 SRD5A2 (0.43) NPC1RAB9AKDM4ESMN1; SMN2MAPT
SCHEMBL2157466 0.80 IKBKB (0.42) SMN1; SMN2MAPT
SCHEMBL14043019 0.80 P2RX7 (0.35) SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008043791-A2 THIOPHENE DERIVATIVES FOR TREATING HEPATITIS C SMITHKLINE BEECHAM CORPORATION (US) 2008-04-17 — — WO claimed
WO-2008043791-A2 THIOPHENE DERIVATIVES FOR TREATING HEPATITIS C SMITHKLINE BEECHAM CORPORATION (US) 2008-04-17 — — WO disclosed
WO-2008043791-A2 THIOPHENE DERIVATIVES FOR TREATING HEPATITIS C SMITHKLINE BEECHAM CORPORATION (US) 2008-04-17 — — WO disclosed
Send feedback